menu
    • menu

    Company profile for Azalea Therapeutics

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Azalea Therapeutics is advancing precision genome engineering inside the body, delivering therapies with unmatched accuracy first to the right cells, then to the exact genetic locus. Focused initially on in vivo cancer immunotherapies, Azalea is pioneering a new approach to engineer a patient’s own T cells directly in the body. Using Enveloped Delivery Vehicles (EDVs), our platform targets T cells with exceptional selectivit...
    Azalea Therapeutics is advancing precision genome engineering inside the body, delivering therapies with unmatched accuracy first to the right cells, then to the exact genetic locus. Focused initially on in vivo cancer immunotherapies, Azalea is pioneering a new approach to engineer a patient’s own T cells directly in the body. Using Enveloped Delivery Vehicles (EDVs), our platform targets T cells with exceptional selectivity and inserts therapeutic payloads at precise genomic sites, enabling safer, faster, and more accessible cell therapies with the potential to transform cancer treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Azalea TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2625 Durant Ave. Berkeley, CA, 94720
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://azaleatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/azalea-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Azalea Pharma Showcases In Vivo TRAC-CAR T Cell Engineering
    Azalea Pharma Showcases In Vivo TRAC-CAR T Cell Engineering

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258448/0/en/Azalea-Therapeutics-Highlights-Nature-Publication-Demonstrating-In-Vivo-Site-Specific-TRAC-CAR-T-Cell-Engineering.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Azalea Show Strong Preclinical TRAC-CAR T Data Using EDV Delivery
    Azalea Show Strong Preclinical TRAC-CAR T Data Using EDV Delivery

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192000/0/en/Azalea-Therapeutics-Presents-New-Preclinical-Data-Demonstrating-Robust-In-Vivo-Generation-of-TRAC-CAR-T-Cells-Using-Enveloped-Delivery-Vehicles-EDVs.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Azalea Launches With $82M to Advance Precision Genomic Medicines
    Azalea Launches With $82M to Advance Precision Genomic Medicines

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180290/0/en/Azalea-Therapeutics-Launches-with-82-Million-Financing-to-Redefine-Precision-Genomic-Medicines-by-Engineering-Cells-Directly-Inside-Each-Patient.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search